DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Weinstein C, Jordan K, Green SA, Khanani S, Beckford-Brathwaite E. et al.
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: Results of a randomized, double-blind phase III trial.
Ann Oncol 2016;
27: 172-8
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.